COMMUNIQUÉS West-GlobeNewswire

GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
30/10/2025
GENFIT’s decision to delist from Nasdaq reflects strategic intent to simplify corporate structure and improve operational efficiency GENFIT remains listed on the regulated market of Euronext Paris as its primary trading [...]
GENFIT annonce son intention de procéder au retrait volontaire de la cotation de ses « American Depositary Shares » sur le Nasdaq Global Select Market
30/10/2025
La décision de GENFIT de retrait du Nasdaq traduit une volonté stratégique de simplifier sa structure organisationnelle et d'améliorer son efficacité opérationnelle Les actions de GENFIT restent cotées sur le marché [...]
CROSSJECT annonce la mise à disposition du rapport financier semestriel au 30 juin 2025
30/10/2025
Communiqué de presse CROSSJECT annonce la mise à disposition du rapport financier semestriel au 30 juin 2025 DIJON, France – 30 octobre 2025 (20H00 CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société [...]
‘Do I Qualify for Lung Cancer Screening?’: Understanding Your Path to Early Detection Could Save Your Life
30/10/2025
While other organized screening programs are well-established, organized lung cancer screening remains less familiar to many Canadians, yet it’s a crucial and accessible way to protect your health. Lung Health [...]
Nkarta to Participate in November Investor Conferences
30/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
30/10/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 30 octobre 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Psychologie Berlin's Dr. Dirk Stemper Announces New Book: The Vagus Nerve: Why You Don’t Need a Reset – Real Neuromodulation for Exhaustion, Trauma, and Long COVID
30/10/2025
New book reveals evidence-based approaches for nervous system dysfunction—debunking quick fixes and offering actionable strategies in neuromodulation, biofeedback, and trauma recovery. Vagus Nerve—Science, Not Myth: Dr [...]
Wounded Warriors Family Support, AMVET Power Announce Strategic Partnership to Empower Veterans
30/10/2025
OMAHA, Neb., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Wounded Warriors Family Support and AMVET Power have announced a new charity partnership dedicated to enhancing support for our nation's wounded veterans, their families [...]
Good Samaritan President and CEO Honoured Among Canada’s Most Powerful Women
30/10/2025
EDMONTON, Alberta, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Good Samaritan Society and Good Samaritan Canada (Good Samaritan) are proud to announce that Dr. Katherine Chubbs, President and CEO, has been named one of Canada [...]
Resuscitec’s CARL® ECPR System Wins the Prix Galien USA 2025 “Best Startup” Award
30/10/2025
Industry’s top honor recognizes Resuscitec’s life-restoring technology redefining outcomes after sudden cardiac arrest NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Resuscitec GmbH today announced that its CARL® ECPR [...]
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
30/10/2025
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the [...]
11 New Living Soil THCA Strains Now Available at The Hemp Doctor
30/10/2025
MOORESVILLE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, a leader in offering premium hemp-derived products, has expanded its THCA flower collection with 11 new strains grown in living soil. This [...]
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
30/10/2025
LA PALMA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered [...]
Kaida BioPharma Selected to Present at Two Upcoming Conferences
30/10/2025
Premier presenter semi-finalist for BIOPITCH at the Florida Innovation Conference Startup finalist for Tampa Tank Pitch Competition at the Disrupt the Bay Conference featuring Keynote Speaker, Cathie Wood from Ark [...]
Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
30/10/2025
Selects Greenstone Biosciences to Accelerate AI-Driven iPSC Precision Medicine Platform PHOENIX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “ [...]
Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics in the Free to Be Me Campaign, Urging People With Inflammatory Skin Conditions to Speak With Their Healthcare Provider About Long-Term Treatments
30/10/2025
Tori Spelling shares her and her family’s journey with eczema and seborrheic dermatitis to encourage others to take control of their skin health ZORYVE® (roflumilast) is the #1 prescribed branded topical therapy for [...]
Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting
30/10/2025
WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]
Nouscom to Present New Positive Phase 1b/2 Clinical and Translational Data on NOUS-209 Immunogenicity and Cancer Interception Potential in Lynch Syndrome Carriers at SITC 2025
30/10/2025
Lynch Syndrome (LS) is a common hereditary condition that greatly increases lifetime risk of colorectal, endometrial, urothelial and other cancers NOUS-209 is an off-the-shelf immunotherapy designed to harness the power [...]
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
30/10/2025
BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients [...]

Pages